AGP Limited (PSX:AGP)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
196.28
-21.81 (-10.00%)
At close: Mar 2, 2026
3.46%
Market Cap 54.96B
Revenue (ttm) 27.73B
Net Income (ttm) 3.69B
Shares Out 280.00M
EPS (ttm) 13.19
PE Ratio 14.88
Forward PE 12.34
Dividend 4.00 (1.83%)
Ex-Dividend Date Sep 2, 2025
Volume 245,306
Average Volume 1,011,114
Open 200.01
Previous Close 218.09
Day's Range 196.28 - 208.00
52-Week Range 142.00 - 258.67
Beta 0.24
RSI 36.29
Earnings Date Mar 2, 2026

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1989
Employees 2,143
Stock Exchange Pakistan Stock Exchange
Ticker Symbol AGP
Full Company Profile

Financial Performance

In 2024, AGP Limited's revenue was 25.03 billion, an increase of 33.56% compared to the previous year's 18.74 billion. Earnings were 2.67 billion, an increase of 70.58%.

Financial Statements

News

There is no news available yet.